Search

Your search keyword '"Hensch, Tilman"' showing total 289 results

Search Constraints

Start Over You searched for: Author "Hensch, Tilman" Remove constraint Author: "Hensch, Tilman"
289 results on '"Hensch, Tilman"'

Search Results

52. P2‐101: Aβ/PHOSPHO TAU LOAD IN CSF IS RELATED TO CORTICAL EXCITABILITY AS REVEALED BY CORTICAL EEG BIOMARKERS IN PATIENTS WITH PRODROMAL ALZHEIMER'S DISEASE: THE PHARMACOG PROJECT

53. IC‐P‐126: VOLUMETRIC ACCURACY OF A FULLY AUTOMATIC TOOL FOR WHITE MATTER HYPERINTENSITIES (WMHS) SEGMENTATION

55. CSF Beta-Amyloid and APOE E4 Related Decline in Episodic Memory over 12 months measured using the CANTAB in individuals with amnestic MCI: Results from the European-ADNI study

57. [IC-P-167]: ACROSS-SESSION REPRODUCIBILITY OF AUTOMATIC WHITE MATTER HYPERINTENSITIES SEGMENTATION: A EUROPEAN MULTI-SITE 3T STUDY

58. [P4–160]: BACK‐TRANSLATION OF EEG/ERP MARKERS FROM AMNESTIC MCI PATIENTS TO HEALTHY YOUNG VOLUNTEERS IN THE PHARMACOG PROJECT

59. ACROSS-SESSION REPRODUCIBILITY OF AUTOMATIC WHITE MATTER HYPERINTENSITIES SEGMENTATION: A EUROPEAN MULTI-SITE 3T STUDY

62. The LIFE-Adult-Study: Objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in Germany

63. Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity.

64. Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers.

65. PT593. CSF Beta-Amyloid and APOE E4 Related Decline in Episodic Memory over 12 months measured using the CANTAB in individuals with amnestic MCI: Results from the European-ADNI study

66. Genetic Association of Objective Sleep Phenotypes with a Functional Polymorphism in the Neuropeptide S Receptor Gene

68. Sleep disturbances and upregulation of brain arousal during daytime in depressed versus non-depressed elderly subjects

70. P3-057: Association Between EEG/ERP and CSF Markers in Prodromal Alzheimer’s Disease in the Pharmacog Project

71. P3-056: Back-Translation of EEG/ERP Markers from Amnestic MCI Patients to Healthy Young Volunteers in the Pharmacog Project

72. P3-315: Differential Effects of Apoe and CSF Amyloid on Memory Impairment in Individuals with Amnestic MCI Using the Cantab Cognitive Battery: Results from the European-Adni Study

73. P2-302: CSF Beta-Amyloid- and APOE Ɛ4-Related Decline in Episodic Memory Over 12 Months Measured using the Cantab in Individuals with Amnestic MCI: Results from the European ADNI Study

74. Time to wake up: No impact of COMT Val158Met gene variation on circadian preferences, arousal regulation and sleep

76. VOLUMETRIC ACCURACY OF A FULLY AUTOMATIC TOOL FOR WHITE MATTER HYPERINTENSITIES (WMHS) SEGMENTATION

77. Aβ/PHOSPHO TAU LOAD IN CSF IS RELATED TO CORTICAL EXCITABILITY AS REVEALED BY CORTICAL EEG BIOMARKERS IN PATIENTS WITH PRODROMAL ALZHEIMER'S DISEASE: THE PHARMACOG PROJECT

78. Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage

79. cover Disease Tracking Markers for Alzheimer's Disease at the Prodromal (MCI) Stage

81. The LIFE-Adult-Study: objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in Germany

82. P2‐176: Are cortical sources of auditory oddball event‐related potentials an early diagnostic marker of Alzheimer's disease?

83. P2-188: Characterization of cognitive function with the cantab in individuals with amnestic mild cognitive impairment in relation to hippocampal volume, amyloid, and tau status: Preliminary baseline results from the PharmaCog/european-ADNI study

84. P2-175: Are cortical sources of resting state eyes-closed electroencephalographic rhythms an early diagnostic marker of Alzheimer's disease?

86. Brain Arousal Regulation in Carriers of Bipolar Disorder Risk Alleles

87. Genetic association of objective sleep phenotypes with a functional polymorphism in the neuropeptide S receptor gene

88. Sleep disturbances and upregulation of brain arousal during daytime in depressed versus non-depressed elderly subjects.

89. P1-216: FRONTAL CORTICAL SOURCES OF AUDITORY ODDBALL EVENT-RELATED POTENTIALS ARE RELATED TO CEREBROSPINAL FLUID β AMYLOID IN AMNESTIC MCI SUBJECTS

90. P1-215: CORTICAL SOURCES OF RESTING STATE EYES CLOSED EEG RHYTHMS ARE CORRELATED TO CEREBROSPINAL FLUID β AMYLOID IN AMNESTIC MCI SUBJECTS

91. DIFFERENTIAL EFFECTS OF APOE AND CSF AMYLOID ON MEMORY IMPAIRMENT IN INDIVIDUALS WITH AMNESTIC MCI USING THE CANTAB COGNITIVE BATTERY: RESULTS FROM THE EUROPEAN-ADNI STUDY

92. ASSOCIATION BETWEEN EEG/ERP AND CSF MARKERS IN PRODROMAL ALZHEIMER’S DISEASE IN THE PHARMACOG PROJECT

93. BACK-TRANSLATION OF EEG/ERP MARKERS FROM AMNESTIC MCI PATIENTS TO HEALTHY YOUNG VOLUNTEERS IN THE PHARMACOG PROJECT

94. CSF BETA-AMYLOID- AND APOE Ɛ4-RELATED DECLINE IN EPISODIC MEMORY OVER 12 MONTHS MEASURED USING THE CANTAB IN INDIVIDUALS WITH AMNESTIC MCI: RESULTS FROM THE EUROPEAN ADNI STUDY

95. Electrophysiological and behavioral correlates of polymorphisms in the transcription factor AP-2beta coding gene

96. Brain morphometry reproducibility in multi-center 3T MRI studies: A comparison of cross-sectional and longitudinal segmentations

97. P3-121: Test-retest reproducibility of brain morphometry, diffusion and resting-state fMRI: A 3T consortium study

98. IC-P-044: Test-retest reproducibility of brain morphometry, diffusion and resting-state fMRI: A 3T consortium study

100. Assessment of Wakefulness and Brain Arousal Regulation in Psychiatric Research.

Catalog

Books, media, physical & digital resources